GH Research | SC 13G/A:超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(12.9%),Peter Kolchinsky(12.9%)等
GH Research | SC 13G/A:超过5%持股股东披露文件(修正)-Lynx1 Capital Management LP(8.1%),Weston Nichols(8.1%)
GH Research | 6-K:外国发行人报告(业绩相关)
GH Research | 6-K:外国发行人报告
GH Research | 6-K:外国发行人报告
GH Research | 6-K:外国发行人报告
GH Research | 6-K:外国发行人报告
GH Research | 6-K:外国发行人报告
GH Research | 6-K:外国发行人报告(业绩相关)
GH Research | 6-K:外国发行人报告
GH Research | 6-K:外国发行人报告
GH Research | 6-K:外国发行人报告(业绩相关)
GH Research | 6-K:外国发行人报告(业绩相关)
GH Research | 6-K:外国发行人报告
GH Research | 6-K:外国发行人报告
GH Research | 20-F:2023财年年报
GH Research | 6-K:外国发行人报告(业绩相关)
GH Research | SC 13G:超过5%持股股东披露文件-Lynx1 Capital Management LP(5.8%),Weston Nichols(5.8%)
GH Research | SC 13G/A:超过5%持股股东披露文件(修正)-Venrock Healthcare Capital Partners II, L.P.(2.5%),VHCP Co-Investment Holdings II, LLC(2.5%)等
GH Research | SC 13G/A:超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(10.7%),Peter Kolchinsky(10.7%)等
暂无数据
暂无数据